Cargando…

Biomimetic Membranes as a Technology Platform: Challenges and Opportunities

Biomimetic membranes are attracting increased attention due to the huge potential of using biological functional components and processes as an inspirational basis for technology development. Indeed, this has led to several new membrane designs and applications. However, there are still a number of...

Descripción completa

Detalles Bibliográficos
Autor principal: Hélix-Nielsen, Claus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161077/
https://www.ncbi.nlm.nih.gov/pubmed/30018213
http://dx.doi.org/10.3390/membranes8030044
_version_ 1783358911740379136
author Hélix-Nielsen, Claus
author_facet Hélix-Nielsen, Claus
author_sort Hélix-Nielsen, Claus
collection PubMed
description Biomimetic membranes are attracting increased attention due to the huge potential of using biological functional components and processes as an inspirational basis for technology development. Indeed, this has led to several new membrane designs and applications. However, there are still a number of issues which need attention. Here, I will discuss three examples of biomimetic membrane developments within the areas of water treatment, energy conversion, and biomedicine with a focus on challenges and applicability. While the water treatment area has witnessed some progress in developing biomimetic membranes of which some are now commercially available, other areas are still far from being translated into technology. For energy conversion, there has been much focus on using bacteriorhodopsin proteins, but energy densities have so far not reached sufficient levels to be competitive with state-of-the-art photovoltaic cells. For biomedical (e.g., drug delivery) applications the research focus has been on the mechanism of action, and much less on the delivery ‘per se’. Thus, in order for these areas to move forward, we need to address some hard questions: is bacteriorhodopsin really the optimal light harvester to be used in energy conversion? And how do we ensure that biomedical nano-carriers covered with biomimetic membrane material ever reach their target cells/tissue in sufficient quantities? In addition to these area-specific questions the general issue of production cost and scalability must also be treated in order to ensure efficient translation of biomimetic membrane concepts into reality.
format Online
Article
Text
id pubmed-6161077
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-61610772018-09-28 Biomimetic Membranes as a Technology Platform: Challenges and Opportunities Hélix-Nielsen, Claus Membranes (Basel) Review Biomimetic membranes are attracting increased attention due to the huge potential of using biological functional components and processes as an inspirational basis for technology development. Indeed, this has led to several new membrane designs and applications. However, there are still a number of issues which need attention. Here, I will discuss three examples of biomimetic membrane developments within the areas of water treatment, energy conversion, and biomedicine with a focus on challenges and applicability. While the water treatment area has witnessed some progress in developing biomimetic membranes of which some are now commercially available, other areas are still far from being translated into technology. For energy conversion, there has been much focus on using bacteriorhodopsin proteins, but energy densities have so far not reached sufficient levels to be competitive with state-of-the-art photovoltaic cells. For biomedical (e.g., drug delivery) applications the research focus has been on the mechanism of action, and much less on the delivery ‘per se’. Thus, in order for these areas to move forward, we need to address some hard questions: is bacteriorhodopsin really the optimal light harvester to be used in energy conversion? And how do we ensure that biomedical nano-carriers covered with biomimetic membrane material ever reach their target cells/tissue in sufficient quantities? In addition to these area-specific questions the general issue of production cost and scalability must also be treated in order to ensure efficient translation of biomimetic membrane concepts into reality. MDPI 2018-07-17 /pmc/articles/PMC6161077/ /pubmed/30018213 http://dx.doi.org/10.3390/membranes8030044 Text en © 2018 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Hélix-Nielsen, Claus
Biomimetic Membranes as a Technology Platform: Challenges and Opportunities
title Biomimetic Membranes as a Technology Platform: Challenges and Opportunities
title_full Biomimetic Membranes as a Technology Platform: Challenges and Opportunities
title_fullStr Biomimetic Membranes as a Technology Platform: Challenges and Opportunities
title_full_unstemmed Biomimetic Membranes as a Technology Platform: Challenges and Opportunities
title_short Biomimetic Membranes as a Technology Platform: Challenges and Opportunities
title_sort biomimetic membranes as a technology platform: challenges and opportunities
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161077/
https://www.ncbi.nlm.nih.gov/pubmed/30018213
http://dx.doi.org/10.3390/membranes8030044
work_keys_str_mv AT helixnielsenclaus biomimeticmembranesasatechnologyplatformchallengesandopportunities